Invus Global Management, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Syros Pharmaceuticals, Inc. (SYRS)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Invus Public Equities, L.P.
Security
Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share
Symbol
SYRS
Shares outstanding
28M shares
Disclosed Ownership
1.06M shares
Ownership
3.8%
Form type
SCHEDULE 13G/A
Date filed
2/12/2025, 04:30 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 3.8% 1.06M 1.06M 0 /s/ Raymond Debbane Raymond Debbane, President, Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 3.8% 1.06M 1.06M 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 3.8% 1.06M 1.06M 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 3.8% 1.06M 1.06M 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 0% 0 0 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer, Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 0% 0 0 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 0% 0 0 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 3.8% 1.06M 1.06M 0 /s/ Raymond Debbane Raymond Debbane